Top

BY Cynthia DeMarco

CAR T cell therapy is a type of immunotherapy used to treat lymphoma, multiple myeloma and some forms of leukemia. The treatment modifies T cells so that they can better recognize and attack cancer. 

To learn what to expect if you need CAR T cell therapy, we spoke with lymphoma and myeloma specialist Sairah Ahmed, M.D.

Your care team will determine if you’re eligible for CAR T cell therapy

Before you can consider...

Medical illustration of a CAR T cell in action

BY Maggie Galehouse

Rappelling up a rock-climbing wall was Akilah Lopez’s greatest challenge at MD Anderson’s Camp Family Fun Day in August 2022.

“They...

BY Clayton Boldt, Ph.D.

From unlocking the secrets of the tumor microenvironment to advancing new therapies to FDA approval, MD Anderson researchers are driven by...

BY KirstiAnn Clifford

Last updated Jan. 26, 2023

Allie Moreno has a simple yet powerful message for people who donate blood at MD Anderson: “Thank you. Your selfless act saves lives and was essential to my recovery.” 

She received multiple blood transfusions throughout her non-Hodgkin lymphoma treatment at MD Anderson, as the chemotherapy caused anemia and low blood cell counts. 

“I never knew the importance of blood until I...

Lymphoma survivor Allie Moreno sits with her son surrounded by toys

BY Cynthia DeMarco

When Arav Patil was diagnosed with acute myeloid leukemia (AML) in the spring of 2019, his parents, Komal and Rahul, were dumbfounded....

BY Sairah Ahmed, M.D. and Elizabeth Shpall, M.D.

Since MD Anderson’s first CAR T cell therapy clinical trial launched in 2015, we’ve cared for hundreds of patients undergoing CAR T cell therapy...

BY Algimantė Daugėlaitė

By the time I got to MD Anderson in March 2021, I’d already been through two cancer diagnoses, three relapses, six types of chemotherapy and...

BY Cynthia DeMarco

How many types of leukemia are there? What makes each one unique, and are they treated any differently? 

We went to leukemia specialist...

BY Ronda Wendler

Carolyn Drone thought her days of coping with cancer were over. She’d finished leukemia treatment two years earlier and showed no signs of...

BY Sister Shirley Vaughn

When I was first diagnosed with Philadelphia-positive chronic myeloid leukemia in 1989, there weren’t that many treatment options available...